The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Labeled Peptides-Global Market Insights and Sales Trends 2024
Synopsis
Labeled Peptides with stable, non-radioactive isotopes are increasingly used for convenient detection in research. Isotope–labeled, or ‘heavy’ amino acids, are derived from natural amino acids by substitution of certain atoms (N, C, H) with their ‘heavy isotope’ variant. The most frequently substitutions are 12C by 13C (carbon-13), 14N by 15N (nitrogen-15), and 1H by 2H (deuterium).
The global Labeled Peptides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Labeled Peptides in various end use industries. The expanding demands from the Protein Chemistry, Immunology, Histochemistry and Others, are propelling Labeled Peptides market. (Arg)9, FAM-labeled, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the (Arg)9, TAMRA-labeled segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Labeled Peptides market, driven by demand from China, the second largest economy with some signs of stabilising, the Labeled Peptides market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Labeled Peptides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Labeled Peptides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Labeled Peptides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Labeled Peptides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Labeled Peptides covered in this report include Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein and Eurogentec, etc.
The global Labeled Peptides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pepscan
JPT Peptide Technologies
PEPTIDE INSTITUTE
Merck
BIOSYNTAN GmbH
LifeTein
Eurogentec
Global Labeled Peptides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Labeled Peptides market, Segment by Type:
(Arg)9, FAM-labeled
(Arg)9, TAMRA-labeled
Others
Global Labeled Peptides market, by Application
Protein Chemistry
Immunology
Histochemistry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Labeled Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Labeled Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Labeled Peptides with stable, non-radioactive isotopes are increasingly used for convenient detection in research. Isotope–labeled, or ‘heavy’ amino acids, are derived from natural amino acids by substitution of certain atoms (N, C, H) with their ‘heavy isotope’ variant. The most frequently substitutions are 12C by 13C (carbon-13), 14N by 15N (nitrogen-15), and 1H by 2H (deuterium).
The global Labeled Peptides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Labeled Peptides in various end use industries. The expanding demands from the Protein Chemistry, Immunology, Histochemistry and Others, are propelling Labeled Peptides market. (Arg)9, FAM-labeled, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the (Arg)9, TAMRA-labeled segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Labeled Peptides market, driven by demand from China, the second largest economy with some signs of stabilising, the Labeled Peptides market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Labeled Peptides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Labeled Peptides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Labeled Peptides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Labeled Peptides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Labeled Peptides covered in this report include Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein and Eurogentec, etc.
The global Labeled Peptides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pepscan
JPT Peptide Technologies
PEPTIDE INSTITUTE
Merck
BIOSYNTAN GmbH
LifeTein
Eurogentec
Global Labeled Peptides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Labeled Peptides market, Segment by Type:
(Arg)9, FAM-labeled
(Arg)9, TAMRA-labeled
Others
Global Labeled Peptides market, by Application
Protein Chemistry
Immunology
Histochemistry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Labeled Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Labeled Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Labeled Peptides Market Overview
1.1 Labeled Peptides Product Overview
1.2 Labeled Peptides Market Segment by Type
1.2.1 (Arg)9, FAM-labeled
1.2.2 (Arg)9, TAMRA-labeled
1.2.3 Others
1.3 Global Labeled Peptides Market Size by Type
1.3.1 Global Labeled Peptides Market Size Overview by Type (2018-2029)
1.3.2 Global Labeled Peptides Historic Market Size Review by Type (2018-2023)
1.3.3 Global Labeled Peptides Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Labeled Peptides Sales Breakdown by Type (2018-2023)
1.4.2 Europe Labeled Peptides Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Labeled Peptides Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Labeled Peptides Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Labeled Peptides Sales Breakdown by Type (2018-2023)
2 Global Labeled Peptides Market Competition by Company
2.1 Global Top Players by Labeled Peptides Sales (2018-2023)
2.2 Global Top Players by Labeled Peptides Revenue (2018-2023)
2.3 Global Top Players by Labeled Peptides Price (2018-2023)
2.4 Global Top Manufacturers Labeled Peptides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Labeled Peptides Market Competitive Situation and Trends
2.5.1 Labeled Peptides Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Labeled Peptides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Labeled Peptides as of 2022)
2.7 Date of Key Manufacturers Enter into Labeled Peptides Market
2.8 Key Manufacturers Labeled Peptides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Labeled Peptides Status and Outlook by Region
3.1 Global Labeled Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Labeled Peptides Historic Market Size by Region
3.2.1 Global Labeled Peptides Sales in Volume by Region (2018-2023)
3.2.2 Global Labeled Peptides Sales in Value by Region (2018-2023)
3.2.3 Global Labeled Peptides Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Labeled Peptides Forecasted Market Size by Region
3.3.1 Global Labeled Peptides Sales in Volume by Region (2024-2029)
3.3.2 Global Labeled Peptides Sales in Value by Region (2024-2029)
3.3.3 Global Labeled Peptides Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Labeled Peptides by Application
4.1 Labeled Peptides Market Segment by Application
4.1.1 Protein Chemistry
4.1.2 Immunology
4.1.3 Histochemistry
4.1.4 Others
4.2 Global Labeled Peptides Market Size by Application
4.2.1 Global Labeled Peptides Market Size Overview by Application (2018-2029)
4.2.2 Global Labeled Peptides Historic Market Size Review by Application (2018-2023)
4.2.3 Global Labeled Peptides Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Labeled Peptides Sales Breakdown by Application (2018-2023)
4.3.2 Europe Labeled Peptides Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Labeled Peptides Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Labeled Peptides Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Labeled Peptides Sales Breakdown by Application (2018-2023)
5 North America Labeled Peptides by Country
5.1 North America Labeled Peptides Historic Market Size by Country
5.1.1 North America Labeled Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Labeled Peptides Sales in Volume by Country (2018-2023)
5.1.3 North America Labeled Peptides Sales in Value by Country (2018-2023)
5.2 North America Labeled Peptides Forecasted Market Size by Country
5.2.1 North America Labeled Peptides Sales in Volume by Country (2024-2029)
5.2.2 North America Labeled Peptides Sales in Value by Country (2024-2029)
6 Europe Labeled Peptides by Country
6.1 Europe Labeled Peptides Historic Market Size by Country
6.1.1 Europe Labeled Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Labeled Peptides Sales in Volume by Country (2018-2023)
6.1.3 Europe Labeled Peptides Sales in Value by Country (2018-2023)
6.2 Europe Labeled Peptides Forecasted Market Size by Country
6.2.1 Europe Labeled Peptides Sales in Volume by Country (2024-2029)
6.2.2 Europe Labeled Peptides Sales in Value by Country (2024-2029)
7 Asia-Pacific Labeled Peptides by Region
7.1 Asia-Pacific Labeled Peptides Historic Market Size by Region
7.1.1 Asia-Pacific Labeled Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Labeled Peptides Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Labeled Peptides Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Labeled Peptides Forecasted Market Size by Region
7.2.1 Asia-Pacific Labeled Peptides Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Labeled Peptides Sales in Value by Region (2024-2029)
8 Latin America Labeled Peptides by Country
8.1 Latin America Labeled Peptides Historic Market Size by Country
8.1.1 Latin America Labeled Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Labeled Peptides Sales in Volume by Country (2018-2023)
8.1.3 Latin America Labeled Peptides Sales in Value by Country (2018-2023)
8.2 Latin America Labeled Peptides Forecasted Market Size by Country
8.2.1 Latin America Labeled Peptides Sales in Volume by Country (2024-2029)
8.2.2 Latin America Labeled Peptides Sales in Value by Country (2024-2029)
9 Middle East and Africa Labeled Peptides by Country
9.1 Middle East and Africa Labeled Peptides Historic Market Size by Country
9.1.1 Middle East and Africa Labeled Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Labeled Peptides Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Labeled Peptides Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Labeled Peptides Forecasted Market Size by Country
9.2.1 Middle East and Africa Labeled Peptides Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Labeled Peptides Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pepscan
10.1.1 Pepscan Company Information
10.1.2 Pepscan Introduction and Business Overview
10.1.3 Pepscan Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pepscan Labeled Peptides Products Offered
10.1.5 Pepscan Recent Development
10.2 JPT Peptide Technologies
10.2.1 JPT Peptide Technologies Company Information
10.2.2 JPT Peptide Technologies Introduction and Business Overview
10.2.3 JPT Peptide Technologies Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.2.4 JPT Peptide Technologies Labeled Peptides Products Offered
10.2.5 JPT Peptide Technologies Recent Development
10.3 PEPTIDE INSTITUTE
10.3.1 PEPTIDE INSTITUTE Company Information
10.3.2 PEPTIDE INSTITUTE Introduction and Business Overview
10.3.3 PEPTIDE INSTITUTE Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.3.4 PEPTIDE INSTITUTE Labeled Peptides Products Offered
10.3.5 PEPTIDE INSTITUTE Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Labeled Peptides Products Offered
10.4.5 Merck Recent Development
10.5 BIOSYNTAN GmbH
10.5.1 BIOSYNTAN GmbH Company Information
10.5.2 BIOSYNTAN GmbH Introduction and Business Overview
10.5.3 BIOSYNTAN GmbH Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BIOSYNTAN GmbH Labeled Peptides Products Offered
10.5.5 BIOSYNTAN GmbH Recent Development
10.6 LifeTein
10.6.1 LifeTein Company Information
10.6.2 LifeTein Introduction and Business Overview
10.6.3 LifeTein Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.6.4 LifeTein Labeled Peptides Products Offered
10.6.5 LifeTein Recent Development
10.7 Eurogentec
10.7.1 Eurogentec Company Information
10.7.2 Eurogentec Introduction and Business Overview
10.7.3 Eurogentec Labeled Peptides Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Eurogentec Labeled Peptides Products Offered
10.7.5 Eurogentec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Labeled Peptides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Labeled Peptides Industrial Chain Analysis
11.4 Labeled Peptides Market Dynamics
11.4.1 Labeled Peptides Industry Trends
11.4.2 Labeled Peptides Market Drivers
11.4.3 Labeled Peptides Market Challenges
11.4.4 Labeled Peptides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Labeled Peptides Distributors
12.3 Labeled Peptides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
